haloperidol has been researched along with neuropeptide y in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.89) | 18.7374 |
| 1990's | 22 (57.89) | 18.2507 |
| 2000's | 10 (26.32) | 29.6817 |
| 2010's | 3 (7.89) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altenbach, RJ; Brioni, JD; Carr, TL; Chandran, P; Cowart, MD; Esbenshade, TA; Honore, P; Hsieh, GC; Lewis, LG; Liu, H; Manelli, AM; Marsh, KC; Milicic, I; Miller, TR; Strakhova, MI; Vortherms, TA; Wakefield, BD; Wetter, JM; Witte, DG | 1 |
| de Montigny, C; Debonnel, G; Fournier, A; Monnet, FP | 2 |
| Legutko, B; Smiałowska, M | 1 |
| Pelletier, G; Simard, J | 1 |
| Junien, JL; Pascaud, X; Porreca, F; Rivière, PJ | 1 |
| Pelletier, G | 1 |
| de Montigny, C; Debonnel, G; Monnet, FP | 1 |
| Chihara, K; Fukui, K; Ibata, Y; Iguchi, K; Miyake, M; Nakajima, T; Okamura, H; Yanaihara, N | 1 |
| Cazin, L; Danger, JM; Fasolo, A; Jenks, BG; Pelletier, G; Tonon, MC; Vaudry, H | 1 |
| Duffy, O; Junien, JL; Martin, B; Pascaud, X; Roman, FJ; Vauche, D | 1 |
| Kerkerian, L; Nieoullon, A; Salin, P | 1 |
| Li, S; Pelletier, G | 1 |
| Phend, KD; Rustioni, A; Weinberg, RJ | 1 |
| Smiałowska, M | 1 |
| Ganapathy, V; Leibach, FH; Mahesh, VB; Ramamoorthy, JD; Ramamoorthy, S | 1 |
| Davies, JA; Ellis, Y | 1 |
| Bergeron, R; de Montigny, C; Debonnel, G; Gronier, B; Monnet, FP | 1 |
| Bouchard, P; Dumont, Y; Fournier, A; Quirion, R; St-Pierre, S | 1 |
| Bergeron, R; Bouchard, P; de Montigny, C; Debonnel, G; Junien, JL; Monnet, F; Quirion, R; Roman, F | 1 |
| Chihara, K; Kaneda, H; Maeda, K; Sakai, K | 1 |
| Obuchowicz, E | 1 |
| Chang, TK; Cheng, JT; Niu, CS | 1 |
| Ault, DT; Werling, LL | 1 |
| Obuchowicz, E; Turchan, J | 2 |
| Choe, BK; Kim, SK; Kwon, GY; Shin, SW | 1 |
| Gruber, SH; Mathé, AA | 1 |
| Hong, W; Werling, L | 1 |
| Bajkowska, M; Heilig, M; Maj, M; Obuchowicz, E; Przewłocki, R; Smiałowska, M; Turchan, J | 1 |
| Herman, ZS; Obuchowicz, E | 1 |
| Herman, ZS; Krysiak, R; Obuchowicz, E; Smialowska, M; Wieronska, JM | 1 |
| Cahir, M; Kirk, SL; Reynolds, GP | 1 |
| Deng, C; Huang, XF; Zavitsanou, K | 1 |
| Gruber, SH; Mathé, AA; Nomikos, GG | 1 |
| Ferreira, AS; Gattaz, WF; Raposo, NR | 1 |
| Chen, PN; Chu, SC; Hsieh, YS; Kuo, DY; Kuo, MH; Yu, CH | 1 |
| Pałasz, A; Rojczyk, E; Wiaderkiewicz, R | 1 |
1 review(s) available for haloperidol and neuropeptide y
| Article | Year |
|---|---|
Regulation of MSH secretion by neuropeptide Y in amphibians.
Topics: Amphibians; Animals; Brain; Brain Mapping; Dopamine; Fluorescent Antibody Technique; Haloperidol; Melanocyte-Stimulating Hormones; Neuropeptide Y; Peptide Fragments; Peptide YY; Peptides; Pituitary Gland; Structure-Activity Relationship | 1990 |
1 trial(s) available for haloperidol and neuropeptide y
| Article | Year |
|---|---|
Body mass index increase, serum leptin, adiponectin, neuropeptide Y and lipid levels during treatment with olanzapine and haloperidol.
Topics: Adiponectin; Adolescent; Adult; Antipsychotic Agents; Benzodiazepines; Biomarkers; Body Mass Index; Haloperidol; Humans; Leptin; Lipids; Male; Middle Aged; Neuropeptide Y; Olanzapine; Psychiatric Status Rating Scales; Schizophrenia | 2011 |
36 other study(ies) available for haloperidol and neuropeptide y
| Article | Year |
|---|---|
cis-4-(Piperazin-1-yl)-5,6,7a,8,9,10,11,11a-octahydrobenzofuro[2,3-h]quinazolin-2-amine (A-987306), a new histamine H4R antagonist that blocks pain responses against carrageenan-induced hyperalgesia.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzofurans; Carrageenan; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Humans; Hyperalgesia; Ligands; Mice; Molecular Structure; Pain; Peritonitis; Quinazolines; Rats; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; Stereoisomerism; Structure-Activity Relationship | 2008 |
Sigma ligands and neuropeptide Y selectively potentiate the NMDA response in the rat CA3 dorsal hippocampus: in vivo electrophysiological studies.
Topics: Animals; Electrophysiology; Haloperidol; Hippocampus; In Vitro Techniques; Ligands; Neuropeptide Y; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Neuropeptide Y; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, sigma | 1992 |
Haloperidol-induced increase in neuropeptide Y immunoreactivity in the locus coeruleus of the rat brain.
Topics: Animals; Corpus Striatum; Fenclonine; Haloperidol; Immunohistochemistry; Locus Coeruleus; Male; Neurons; Neuropeptide Y; Phenoxybenzamine; Rats; Rats, Inbred Strains | 1992 |
Neuropeptide Y potentiates the N-methyl-D-aspartate response in the CA3 dorsal hippocampus. II. Involvement of a subtype of sigma receptor.
Topics: Animals; Cinnamates; Cyclopropanes; Drug Synergism; Guanidines; Haloperidol; Hippocampus; Male; N-Methylaspartate; Neuropeptide Y; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, sigma; Spiperone | 1992 |
Dopaminergic regulation of pre-proNPY mRNA levels in the rat arcuate nucleus.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Autoradiography; Bromocriptine; Densitometry; Dopamine Agents; Haloperidol; Male; Neuropeptide Y; Nucleic Acid Hybridization; Protein Precursors; Rats; RNA, Messenger | 1991 |
Neuropeptide Y and JO 1784, a selective sigma ligand, alter intestinal ion transport through a common, haloperidol-sensitive site.
Topics: Animals; Cinnamates; Cyclopropanes; Haloperidol; In Vitro Techniques; Intestinal Mucosa; Intestines; Ion Channels; Male; Mice; Mice, Inbred ICR; N-Methylaspartate; Neuropeptide Y; Receptors, Opioid; Receptors, Opioid, delta | 1990 |
Ultrastructural localization of neuropeptide Y in the hypothalamus.
Topics: alpha-Methyltyrosine; Animals; Arcuate Nucleus of Hypothalamus; Colchicine; Haloperidol; Hypothalamus; Immunoenzyme Techniques; Immunohistochemistry; Male; Median Eminence; Methyltyrosines; Neuropeptide Y; Rats; Serotonin; Suprachiasmatic Nucleus; Tyrosine 3-Monooxygenase | 1990 |
Neuropeptide Y selectively potentiates N-methyl-D-aspartate-induced neuronal activation.
Topics: Animals; Aspartic Acid; Drug Synergism; Haloperidol; Iontophoresis; Kainic Acid; Male; N-Methylaspartate; Neurons; Neuropeptide Y; Oxadiazoles; Quisqualic Acid; Rats; Rats, Inbred Strains | 1990 |
Effect of haloperidol on immunoreactive neuropeptide Y in rat cerebral cortex and basal ganglia.
Topics: Animals; Basal Ganglia; Cerebral Cortex; Dose-Response Relationship, Drug; Haloperidol; Immunohistochemistry; Male; Neuropeptide Y; Organ Specificity; Radioimmunoassay; Rats; Rats, Inbred Strains; Reference Values | 1990 |
Neuropeptide Y and peptide YY interact with rat brain sigma and PCP binding sites.
Topics: Animals; Brain Chemistry; Haloperidol; In Vitro Techniques; Male; Neuropeptide Y; Pentazocine; Peptide YY; Peptides; Phenazocine; Phencyclidine; Rats; Rats, Inbred Strains; Receptors, Neurotransmitter; Receptors, Opioid; Receptors, Phencyclidine; Receptors, sigma | 1989 |
Pharmacological characterization of dopaminergic influence on expression of neuropeptide Y immunoreactivity by rat striatal neurons.
Topics: alpha-Methyltyrosine; Animals; Apomorphine; Benzazepines; Cell Count; Corpus Striatum; Dopamine; Female; Haloperidol; Hydroxydopamines; Immunohistochemistry; Methyltyrosines; Neuropeptide Y; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1988 |
The role of dopamine in the control of neuropeptide Y neurons in the rat arcuate nucleus.
Topics: alpha-Methyltyrosine; Animals; Arcuate Nucleus of Hypothalamus; Dopamine; Female; Haloperidol; Immunoenzyme Techniques; Methyltyrosines; Nerve Tissue Proteins; Neuropeptide Y; Rats | 1986 |
An osmium-free method of epon embedment that preserves both ultrastructure and antigenicity for post-embedding immunocytochemistry.
Topics: Animals; Antigens; Brain; Calcitonin Gene-Related Peptide; Epoxy Resins; gamma-Aminobutyric Acid; Glutamic Acid; Glutaral; Histological Techniques; Male; Microscopy, Immunoelectron; Neuropeptide Y; Neuropeptides; Neurotransmitter Agents; Osmium; Preservation, Biological; Rats; Rats, Sprague-Dawley; Substance P | 1995 |
An inhibitory dopaminergic regulation of the neuropeptide Y immunoreactivity expression in the rat cerebral cortex neurons.
Topics: Animals; Benzazepines; Cerebral Cortex; Dopamine; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Haloperidol; Immunohistochemistry; Kinetics; Male; Neurons; Neuropeptide Y; Phenoxybenzamine; Propranolol; Rats; Rats, Wistar; Receptors, Dopamine D1; Reserpine; Sulpiride; Time Factors | 1995 |
Cocaine-sensitive sigma-receptor and its interaction with steroid hormones in the human placental syncytiotrophoblast and in choriocarcinoma cells.
Topics: Choriocarcinoma; Cocaine; Female; Giant Cells; Gonadal Steroid Hormones; Haloperidol; Humans; Ligands; Neuropeptide Y; Phenytoin; Placenta; Pregnancy; Receptors, sigma; Trophoblasts; Tumor Cells, Cultured; Uterine Neoplasms | 1995 |
The effects of sigma ligands on the release of glutamate from rat striatal slices.
Topics: Animals; Corpus Striatum; Female; Glutamic Acid; Haloperidol; In Vitro Techniques; Ligands; Neuropeptide Y; Piperidines; Potassium; Rats; Rats, Wistar; Receptors, sigma | 1994 |
The effects of sigma ligands and of neuropeptide Y on N-methyl-D-aspartate-induced neuronal activation of CA3 dorsal hippocampus neurones are differentially affected by pertussin toxin.
Topics: Animals; Anticonvulsants; Cinnamates; Cyclopropanes; Drug Synergism; GTP-Binding Proteins; Guanidines; Haloperidol; Hippocampus; Ligands; Male; N-Methylaspartate; Neurons; Neuropeptide Y; Pentazocine; Pertussis Toxin; Pyramidal Cells; Quisqualic Acid; Rats; Rats, Sprague-Dawley; Receptors, sigma; Virulence Factors, Bordetella | 1994 |
Evidence for in vivo interactions between neuropeptide Y-related peptides and sigma receptors in the mouse hippocampal formation.
Topics: Animals; Binding, Competitive; Epinephrine; Gastrointestinal Hormones; Haloperidol; Hippocampus; Kinetics; Male; Mice; Mice, Inbred Strains; Neuropeptide Y; Neurotensin; Peptide YY; Peptides; Phenazocine; Receptors, sigma; Vasoactive Intestinal Peptide | 1993 |
In vivo modulation of sigma receptor sites by calcitonin gene-related peptide in the mouse and rat hippocampal formation: radioligand binding and electrophysiological studies.
Topics: Animals; Antipsychotic Agents; Calcitonin Gene-Related Peptide; Dopamine Antagonists; Electrophysiology; Haloperidol; Hippocampus; In Vitro Techniques; Iontophoresis; Male; Membranes; Mice; Narcotics; Neuropeptide Y; Pentazocine; Phenazocine; Pyramidal Cells; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, sigma | 1995 |
Increases in cortical neuropeptide Y and somatostatin concentrations following haloperidol-depot treatment in rats.
Topics: Animals; Cerebral Cortex; Delayed-Action Preparations; Dopamine Antagonists; Haloperidol; Male; Neuropeptide Y; Rats; Rats, Wistar; Somatostatin | 1995 |
Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antipsychotic Agents; Benzazepines; Chlorpromazine; Clozapine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Gene Expression Regulation; Haloperidol; Hypothalamus; Male; Neuropeptide Y; Prazosin; Quinpirole; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride | 1996 |
Activation of alpha 1-adrenoceptors to lower cerebrocortical neuropeptide Y (NPY)-like immunoreactivity in rats receiving pargyline treatment.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antibody Specificity; Cerebral Cortex; Dopamine Antagonists; Haloperidol; Injections, Intraventricular; Male; Methoxamine; Monoamine Oxidase Inhibitors; Neuropeptide Y; Pargyline; Prazosin; Propranolol; Radioimmunoassay; Rats; Rats, Wistar | 1996 |
Differential modulation of NMDA-stimulated [3H]dopamine release from rat striatum by neuropeptide Y and sigma receptor ligands.
Topics: Analgesics; Animals; Corpus Striatum; Cyclohexylamines; Dopamine; Dose-Response Relationship, Drug; Ethylamines; Haloperidol; Male; N-Methylaspartate; Neuropeptide Y; Piperidines; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, sigma | 1997 |
Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum.
Topics: Adrenergic Antagonists; Animals; Antipsychotic Agents; Chlorpromazine; Clozapine; Corpus Striatum; Dopamine Antagonists; Haloperidol; In Situ Hybridization; Injections, Intraperitoneal; Male; Neuropeptide Y; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Dopamine; Receptors, Serotonin; RNA, Messenger; Serotonin Antagonists; Sulpiride | 1998 |
Effects of acute or long-term treatment with chlorpromazine, haloperidol or sulpiride on neuropeptide Y-like immunoreactivity concentrations in the nucleus accumbens of rat.
Topics: Animals; Antipsychotic Agents; Chlorpromazine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Haloperidol; Immunohistochemistry; In Situ Hybridization; Male; Neuropeptide Y; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D1; RNA, Messenger; Substance Withdrawal Syndrome; Sulpiride; Time Factors | 1999 |
Expression of neuropeptide Y by glutamatergic stimulation in rat C6 glioma cells.
Topics: Animals; Dopamine; Gene Expression Regulation, Neoplastic; Glioma; Glutamic Acid; Haloperidol; Kainic Acid; Muscimol; Neuropeptide Y; Pentylenetetrazole; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Transcription, Genetic; Tumor Cells, Cultured | 2000 |
Effects of typical and atypical antipsychotics on neuropeptide Y in rat brain tissue and microdialysates from ventral striatum.
Topics: Animals; Antipsychotic Agents; Basal Ganglia; Dextroamphetamine; Haloperidol; Male; Microdialysis; Neuropeptide Y; Rats; Rats, Wistar; Risperidone; Sympathomimetics | 2000 |
Lack of effects by sigma ligands on neuropeptide Y-induced G-protein activation in rat hippocampus and cerebellum.
Topics: Analgesics; Animals; Cell Membrane; Cerebellum; Cyclohexylamines; Dopamine Antagonists; GTP Phosphohydrolases; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Hippocampus; Ligands; Male; Neuropeptide Y; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; Receptors, sigma; Subcellular Fractions; Sulfur Radioisotopes | 2001 |
Pharmacological studies on the monoaminergic influence on the synthesis and expression of neuropeptide Y and corticotropin releasing factor in rat brain amygdala.
Topics: Amygdala; Animals; Benzazepines; Corticotropin-Releasing Hormone; Dopamine Antagonists; Fenclonine; Gene Expression; Haloperidol; Immunohistochemistry; In Situ Hybridization; Male; Neuropeptide Y; Rats; Rats, Wistar; RNA, Messenger; Serotonin Antagonists | 2001 |
Effects of haloperidol and clozapine on neuropeptide Y-like immunoreactivity in the nucleus accumbens and striatum of rats pretreated with psychostimulants.
Topics: Amphetamine; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Clozapine; Hallucinogens; Haloperidol; Immunohistochemistry; Male; Motor Activity; Neostriatum; Neuropeptide Y; Nucleus Accumbens; Phencyclidine; Rats; Rats, Wistar; Stereotyped Behavior | 2003 |
Alterations in striatal neuropeptide Y system activity of rats with haloperidol-induced behavioral supersensitivity.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Haloperidol; In Situ Hybridization; Male; Motor Activity; Neuropeptide Y; Quinpirole; Rats; Rats, Wistar; RNA, Messenger | 2005 |
Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus.
Topics: Animals; Antipsychotic Agents; Arcuate Nucleus of Hypothalamus; Clozapine; Haloperidol; Hippocampus; Immunohistochemistry; Male; Neurons; Neuropeptide Y; Rats; Rats, Sprague-Dawley | 2006 |
Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats.
Topics: Animals; Antipsychotic Agents; Benzodiazepines; Brain; Clozapine; Female; Haloperidol; In Situ Hybridization; Mice; Neuropeptide Y; Olanzapine; Rats; RNA, Messenger | 2006 |
Effects of acute and subchronic d-amphetamine on ventral striatal concentrations of neurotensin and neuropeptide Y in rats treated with antipsychotic drugs.
Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Central Nervous System Stimulants; Corpus Striatum; Drug Administration Schedule; Drug Interactions; Extracellular Fluid; Haloperidol; Male; Microdialysis; Neuropeptide Y; Neurotensin; Radioimmunoassay; Rats; Rats, Wistar; Risperidone; Time Factors | 2006 |
Involvement of neuropeptide Y Y1 receptor in the regulation of amphetamine-mediated appetite suppression.
Topics: Amphetamine; Animals; Appetite Depressants; Appetite Regulation; Behavior, Animal; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Tolerance; Eating; Gene Expression Regulation; Haloperidol; Hypothalamus; Male; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Oligonucleotides, Antisense; Rats; Rats, Wistar; Receptor, Melanocortin, Type 3; Receptors, Melanocortin; Receptors, Neuropeptide Y | 2012 |
Effect of short and long-term treatment with antipsychotics on orexigenic/anorexigenic neuropeptides expression in the rat hypothalamus.
Topics: alpha-MSH; Animals; Antipsychotic Agents; Benzodiazepines; Calcium-Binding Proteins; Chlorpromazine; DNA-Binding Proteins; Drug Administration Schedule; Haloperidol; Hypothalamus; Male; Nerve Tissue Proteins; Neuropeptide Y; Nucleobindins; Olanzapine; Orexin Receptors; Orexins; Pro-Opiomelanocortin; Rats; Rats, Sprague-Dawley; Receptor, Melanocortin, Type 4; Receptors, G-Protein-Coupled; Receptors, Neuropeptide | 2015 |